| IND | Indomethacin |
| NSAIDs | Non-steroidal anti-inflammatory drugs |
| COX | Cyclooxygenase |
| COX-1 | Cyclooxygenase-1 |
| COX-2 | Cyclooxygenase-2 |
| GI | Gastrointestinal tract |
| DMI | O-desmethyl-indomethacin |
| DBI | O-deschlorobenzoyl-indomethacin |
| DMBI | O-desmethyl-N-deschlorobenzoyl-indomethacin |
| ACF | Aberrant Crypt Foci |
| AD | Alzheimer’s disease |
| PGs | Prostaglandins |
| CLASS | Celecoxib Long-term Arthritis Safety Study |
| VIGOR | Vioxx Gastrointestinal Outcomes Research |
| FDA | Food and Drug Administration |
| TAG | Triacylglycerol |
| PLA2 | Phospholipase A2 |
| SEDDS | Self-emulsifying Drug Delivery Systems |
| STE | Stearylamine |